Norway vs Spain: Cause of death, by non-communicable diseases, ages 5-14, female
Norway
71.3%
in 2021
Spain
73.6%
in 2021
Norway rank
10th
Spain rank
7th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Norway
- Spain
How they compare
Spain currently reports 73.6% against 71.3% in Norway, a difference of 2.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Spain ahead.
Norway ranks 10th and Spain ranks 7th of 184 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.5% | 60.0% | 15.6% | Spain |
| 2010s | 75.6% | 77.4% | 1.9% | Spain |
| 2020s | 69.7% | 74.5% | 4.8% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Norway or Spain?
- Spain, at 73.6% against 71.3% in Norway as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Norway and Spain?
- 2.3%, with Spain ahead.
- How many years of comparable data are there for Norway and Spain?
- 6 years are reported by both, from 2000 to 2021.
- How do Norway and Spain rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Norway ranks 10th and Spain ranks 7th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.